Development and Validation of Stability Indicating HPTLC Method for Estimation of Dasatinib and Characterization of Degradation Products by Using Mass Spectroscopy
More details
Hide details
Department of Quality Assurance, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, Maharashtra, INDIA
School of Pharmacy and Technology Management, Babulde Banks of Tapi River, Mumbai-Agra Road, Shirpur Dist : Dhule, Maharashtra, INDIA
Online publish date: 2018-05-01
Publish date: 2018-05-01
Eurasian J Anal Chem 2018;13(4):em33
Dasatinib which is available in market as a brand name of Sprycel tablets. Method was validated according to the ICH guidelines. The HPTLC method was developed using Camag HPTLC system. Silica G60 F254 precoated TLC plates were used as stationary phase. Mobile phase was used toluene: methanol (6:4). Dasatinib analysis was carried out in the absorbance mode at 240 nm. The drugs were satisfactorily show peak with RF 0.65 ± 0.03 for Dasatinib. Development method was validated as per ICH guideline using validation parameter like specification, linearity, accuracy, LOD, LOQ, precision, and robustness. The method was found to be linear in the range of 200ng-1.2µg and correlation coefficient value 0.997.dasatinib. In stability testing, Dasatinib were found susceptible to alkaline degradation. Because the method could effectively separate the drugs from their degradation products, it can be used as a stability indicating method. Degradation product of Dasatinib in alkaline condition was carried out and its degradation product is successfully separated and isolated by HPTLC method. Degradation product was identified by using MS-MS technique.
1. ICH. Q2 (R1), harmonized tripartite guideline, validation of analytical procedures: text and methodology. In Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2005.
2. Guoging W, Shamudheen R. First line treatment for chronic myeloid leukemia; Dasatinib, Nilotinib or Imatinib. J. of hematol oncol. 2010;3:47.
3. FDA. FDA approvals additional medical indication for sprycel. Retrieved on 22 March 2013 from
4. Mhaske D, Dhaneshwar S. Stability indicating HPTLC and LC determination of Dasatinib in pharmaceutical dasage form”. Chromatographia. 2007;66:95.
5. Agrawal H, Mahadik K. Stability indicating HPTLC determination of Clopidogrel bisulphate as bulk drug and in pharmaceutical dosage form. Talanta. 2003;61:581-589.
6. Vadera H, Musmade R. Stability indicating HPTLC determination of Imatinib mesylate in bulk drug and pharmaceutical dosage form. J. of Pharmaceutical biomedical analysis. 2007;43:722-726.
7. Antonio D, Avolio GV. HPLC – MS method of the antileukemia drug Imatinib, Dasatinib and Nilotinibin human peripherl blood mononuclear cell. J. of Pharmaceutical and biomed. analysis. 2012;59(5):109-116.
8. Chaudhari R, Krishnapriya M. MS/MS and HPLC characterization of forced degradation products of dutasteride and tamsulosin hydrochloride,” International J. Of Pharmaceutical Sciences And Research. 2014;24:2791-2806.
9. Bhole R, Wankhede SB, Pandey M. Stability Indicating HPTLC Method for Simultaneous Estimation of Empagliflozin and Linagliptin in Pharmaceutical Formulation. Anal Chem Lett. 2017;7(1):76-85.
10. Wankhede SB, Chitlange SS, Bhole RP. Simple and Sensitive “HPTLC Method for Simultaneous Analysis of Thiocolchicoside and Ketoprofen in Combined Dose Tablet Formulation”. Anal Chem Lett. 2012;2(5):301-308.
11. Zhengsheng M, Xin W, Bingxin L, Jing J, Ming X, Youping L. A simplified LC−MS/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study, Anal Bioanal Chem. 2017;409:3025.
12. Bhole RP, Gandhi JS, Wankhede SB. Development and validation of HPTLC method for simultaneous estimation of canagliflozin and metformin hydrochloride in bulk and tablet dosage form, South African Pharmaceutical J. 2017;84(6):43-49.
13. Bhole RP, Shinde SS, Wankhede SB. A High-Performance Thin Layer Chromatography (HPTLC) Method for Simultaneous Determination of Diphenhydramine Hydrochloride and Naproxen Sodium in Tablets, Analytical Chemistry Insights. 2015;10:47-51.
14. ICH Q2A. Guidelines, validation procedure; definition and terminology. 1995:60.
15. ICH Q2B. Validation of analytical procedure; methodology, federal register. 2005;1196(60):27464.
16. Purnachand D, Veerareddy V. Development and validation of a simple and sensitive stability indicating RP-HPLC assay method for determination of Nintedanib and stress degradation studies. Journal of Chemical and Pharmaceutical Research. 2015;7(8):774-782.
17. Bhole RP, Jagdale PD, Wankhede SB, Chitlange SS. A Simple and Sensitive HPTLC Method for Simultaneous Analysis of Phenylephrine hydrochloride and Ketorolac tromethamine in Combined Dose Formulation. Analytical Chemistry Letters. 2015;5(4):206-215.
18. Thorat SG, Chikhale RV. Determination and Pharmacokinetic Study of Pirfenidone in Rat Serum by High-Performance Thin-Layer Chromatography”. Journal of Chromatographic Science. 2016;54(7):1115–1119.
19. Thorat SG, Chikhale RV. The rapid and simple HPTLC assay for therapeutic drug monitoring of capecitabine in colorectal cancer patient Biomedical chromatography. 2018;32(3):4100.